ESR1 and breast carcinoma: Moreover, functional assays suggest that ESR1 IVS1-397C>T polymorphism affects a binding site for the myb family of transcription factors [19], [20] and the polymorphism has also been studied in various breast cancer association studies [17], [21], [22].